Matches 1 - 17 out of 17


Match Document Document Title
DE112004000265B4 Novel photolabile protecting groups for improved methods for the preparation of oligonucleotide arrays  
Use of a compound having the general formula (1): in which R1 COOY, wherein Y is selected from the group consisting of an optionally substituted alkyl group having up to 10 carbon atoms with the...
DE102007007738A1 Color-coded oligosaccharides or polysaccharides  
The Invention relates to color-marked oligosaccharides or polysaccharides, process for producing these color-marked oligosaccharides or polysaccharides and their use for kidney function determination.
DE102006053637B4 Last fluoro-substituted 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of the formula I, which mean X NH; R1 (C1-C6) Alkyl; R4 F; R4 'H, F; R2, R2 ', R3, R3', R5, R5 'independently of one another H, F, Cl, Br, I, OH, - (CH2) -OH, CH2F, CHF2, CF3, NO2, N3,...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102006053635B4 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use  
Compounds of formula and the pharmaceutically acceptable salts thereof.
DE112004000265T5 Novel photolabile protecting groups for improved methods for the preparation of oligonucleotide arrays  
connection having the general formula: where R1 COOY , where Y is selected from the group consisting of an optionally substituted Alkyl group having up to 10 carbon atoms under the condition...
DE19846514A1 New arylmethyl and heterocyclylmethyl substituted heteroaryl-indazole derivatives useful in treatment of cardiovascular, ischemic and urogenital disorders  
1-(Aryl or heterocyclyl)methyl-3-heteroaryl-indazole derivatives are new. The 1-(aryl or heterocyclyl)methyl-3-heteroaryl-indazole derivatives are compounds of formula (I) and their isomers, salts...
DE4430005A1 New malonic acid derivs. of sugars or linear poly:ol  
Malonic acid derivs. of formula (I) are new. R1-R3 = H, (CH2)mX or CH2O(CH2)mX1, or R1+R2 = 6-membered carbocycle or heterocycle substd. by at least one of R4, R5 and R6; A, B = O, S, NH, NHCO,...
DE4402167A1 New moenomycin derivs. with hydroxylated or oxidised lipid side chain  
Moenomycin degradation prods. of formula HX (I) and moenomycin analogues of formula (II) are new. X = a gp. of formula (A). Either (a) R1, R2 = OH or H; R3 = H; and R4, R5 = OH or H; or R4+R5 =...
DE4337630A1 MA having a hydroxylated or oxidised lipid side chain and moenomycin analogues, and a process for the preparation and the use of these compounds  
The invention relates to MA of the formula I in which R<1>, R<2>, R<4> and R<5> independently of one another are a hydroxyl group or hydrogen and R<3> is hydrogen, the bond between the C atom...
DE4326787A1 Synthetic transglycosylase inhibitors, process for their preparation and their use  
The invention relates to transglycosylase inhibitors whose chemical structure is related to that of the moenomycin antibiotics, to the preparation thereof by chemical synthesis and to the use...
DE4345154A1 Moenomycin C1 and derivatives, process for the isolation and derivatisation of moenomycin C1, and the use of moenomycin C1 and its derivatives as antibiotics  
The invention relates to moenomycin C1, to a process for isolating moenomycin C1 from a moenomycin C mixture, to moenomycin C1 derivatives, to a process for preparing moenomycin C1 derivatives and...
DE4315884A1 Moenomycin C1 and derivatives, process for the isolation and derivatisation of moenomycin C1, and use of moenomycin C1 and its derivatives as antibiotics  
The invention relates to moenomycin C1, a process for the isolation of moenomycin C1 from a moenomycin C mixture, moenomycin C1 derivatives, a process for the preparation of moenomycin C1...
DE4113327A1 New bi:cyclic oxazolidinone carbohydrate derivs. - useful in selective synthesis of diastereomers of chiral N-acyl analogues  
Bicyclic oxazolidinone derivs. of formula (I), derived from carbohydrates, are new. In (I) R2 and R2 together complete a carbohydrate ring, in which the OH gps. are protected by acyl (e.g....
DE4204889A1 Prepn. of sialoglycosyl cpds. - including cpds. useful in synthesis of ganglioside(s) and saccharide chain-antigens  
Prepn. of O-glycosyl cpds. (I) of sialic acid comprises reaction of a thioglycoside (II) of sialic acid, in the presence of N-iodosuccinimide (III) and trifluoromethane-sulphonic acid (IV), with a...
DE3704659A1 Moenomycin C3 derivatives, process for their preparation and their use as antibiotics  
The invention relates to the isolation of moenomycin C3 from the moenomycin A/C complex by chromatographic purification, to the elucidation of the structure thereof, to the moenomycin C3...

Matches 1 - 17 out of 17